Global Pharmaceuticals & Biotech Most Popular Stocks

NanoGroup

Market Cap: zł86.8m

Operates as a biotechnology company in Poland.

Kontafarma China Holdings

Market Cap: HK$184.4m

An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.

ChoA Pharmaceutical

Market Cap: ₩33.1b

ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea.

MetaVia

Market Cap: US$23.5m

A clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases.

Matricelf

Market Cap: ₪78.4m

A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions.

SynBiotic

Market Cap: €19.9m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

Xcell Therapeutics

Market Cap: ₩32.9b

Engages in the development and production of drugs for cell therapy.

Propanc Biopharma

Market Cap: US$23.2m

A development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Simply Solventless Concentrates

Market Cap: CA$32.3m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Pharma Equity Group

Market Cap: DKK 147.9m

Through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement.

Neuphoria Therapeutics

Market Cap: US$23.1m

A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.

Lixte Biotechnology Holdings

Market Cap: US$23.1m

A clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Q32 Bio

Market Cap: US$23.1m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction.

Rallybio

Market Cap: US$23.0m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

CytoMed Therapeutics

Market Cap: US$23.0m

A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.

Hoth Therapeutics

Market Cap: US$22.9m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

PuraPharm

Market Cap: HK$177.8m

An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

NanoViricides

Market Cap: US$22.8m

A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Kairos Pharma

Market Cap: US$22.8m

A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

Theranexus Société Anonyme

Market Cap: €19.5m

A biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders.

Argenica Therapeutics

Market Cap: AU$34.7m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia.

Bilcare

Market Cap: ₹2.0b

Provides pharmaceutical packaging research solutions in India and internationally.

Curanex Pharmaceuticals

Market Cap: US$22.4m

A developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.

Pharmsynthez

Market Cap: ₽1.4b

Public Joint-Stock Company ‘Pharmsynthez’, a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia and CIS countries.

Aarey Drugs & Pharmaceuticals

Market Cap: ₹2.0b

Manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.

Optimi Health

Market Cap: CA$30.9m

Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.

Liven Pharmaceuticals

Market Cap: PK₨6.2b

Manufactures and markets pharmaceutical products in Pakistan.

Protect Pharmaceutical

Market Cap: US$21.8m

Primarily focuses on crop farming and agricultural businesses.

Lisata Therapeutics

Market Cap: US$21.6m

A clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.

Avicanna

Market Cap: CA$30.0m

A commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally.

Biomark Diagnostics

Market Cap: €18.4m

Develops early-stage cancer diagnostic technology platform to detect and treat cancer.

Annexin Pharmaceuticals

Market Cap: SEK 201.9m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Alpa Laboratories

Market Cap: ₹1.9b

Engages in the manufacture and sale of drugs and chemicals in India.

Coegin Pharma

Market Cap: SEK 201.0m

A biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden.

HyEnergy

Market Cap: zł77.9m

Provides genetic diagnostic solutions in Poland.

Cingulate

Market Cap: US$21.4m

A biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.